|
|
Pulmonary and Critical Care Medicine 2024 - LIVE STREAMING
Comprehensive Updates for State-of-the-Art Evaluation, Diagnosis, and Treatment
This comprehensive live streaming online course, which is among the highest-rated Harvard Medical School CME courses, provides education and updates to optimize your care of patients with:
• Sepsis
• ARDS
• Sarcoidosis
• IPF
• Bronchiectasis
• Cystic fibrosis
• Lung nodules
• Lung cancer
• GERD
• Pleural disease
• Pneumonia
• Tuberculosis
• Thromboembolism
• Chronic cou... |
|
|
Advancing the Care of Patients Living with EGPA Through Multidisciplinary, Patient-Focused Care
Target Audience
This educational activity is intended for rheumatologists, allergists, immunologists, pulmonologists, and specialty advance practice clinicians who care for patients with EGPA.
Program Overview
The comprehensive program provides up-to-date information regarding EGPA"its recognition, diagnosis, and treatment"and incorporates the patient perspective to raise awareness of patients’ needs, heighten urgency, and, ultimately, educate on the disease. The program will ... |
|
|
The Safety of Opioid Use in Chronic Obstructive Pulmonary Disease
This session will evaluate the safety of opioid therapy among patients with chronic obstructive pulmonary disease (COPD). The session will cover existing safety and effectiveness evidence from clinical trials, and present the latest data from observational studies. The presentation will include a discussion of the strengths and disadvantages of observational study designs along with implications for future practice.
Approximately 15.7 million Americans (6.4%) currently are diagnosed with CO... |
|
|
Developing Optimal Strategies for Reducing Morbidity in Patients with Non-Cystic Fibrosis Bronchiectasis
This case-based morbidity and mortality review (MMR) assesses the negative implications of suboptimal therapeutic management for patients with non-cystic fibrosis bronchiectasis. Cases and expert discussion focus on ensuring a prompt and accurate diagnosis of bronchiectasis, understanding the benefits of high frequency chest wall oscillation (HFCWO), and identifying patients who can benefit from HFCWO. |
|
|
A Patient With Severe Asthma in Need of Additional Control
Severe asthma is thought to affect about 5% to 10% of the total population of patients with asthma. The detrimental consequences of uncontrolled severe asthma are significant, leading to serious exacerbations, deterioration of lung function, and pronounced impact on quality of life. The emergence of biologic therapies has revolutionized the treatment of severe asthma. Dr. Flavia Hoyte consults with Dr. Njira Lugogo to discuss a patient with poorly controlled, late-onset severe disease who may... |
|
|
Clinical Consults in Severe Asthma: New Approaches to Targeted Therapy
As management options for the treatment of severe asthma continue to expand with the addition of effective biologic therapies, physicians often consult colleagues for advice on complex cases or challenging issues. This 3-episode Phone-a-Friend series features 3 expert physicians asking and answering questions related to the management of severe asthma. The series will cover a variety of topics, including patient symptom assessment; disease phenotyping; rationale for treatment escalation or swi... |
|
|
Managing the Patient With Severe Asthma and Common Comorbidities
Comorbid disease is common amongst patients with asthma and may lead to worsening asthma symptoms if not properly identified and managed. Furthermore, some patients may not respond to their first biologic treatment option, confounding management and selection of next line therapy. Dr. Njira Lugogo consults with Dr. Flavia Hoyte to discuss a treatment plan for her patient with severe, allergic asthma and comorbid disease. |
|
|
Ace the Case: Pulmonary Arterial Hypertension (PAH) Treatment Decisions and Therapy Initiation by Pulmonary Hypertension Specialist
Pulmonary hypertension (PH) comprises a heterogeneous group of disorders that share a common clinical feature - mean pulmonary artery pressure greater than 20 mm Hg. PH may involve multiple clinical conditions and may be associated with a variety of cardiovascular and respiratory diseases. Early diagnosis is critical to ensure patients are eligible for the widest spectrum of treatment options and that treatment is initiated as early as possible in the disease process. PH is classified into 5 c... |
|